🇺🇸 FDA
Patent

US 6368593

Enhanced immunogenic cell populations prepared using H2 receptor antagonists

expired A61KA61K2039/5152A61K2239/38

Quick answer

US patent 6368593 (Enhanced immunogenic cell populations prepared using H2 receptor antagonists) held by The Regents of the University of California expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/5152, A61K2239/38, A61K2239/48, A61K2239/50